Announced Mon, 9 Feb · 19:03 IST

PFA

Auditor Resigned MidtermManagement Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Biogen Pharmachem Industries has informed BSE that its Statutory Auditor, M/s Rishi Sekhri and Associates (Chartered Accountants, Membership No. 126656), has resigned effective 9th February 2026. The auditor cited significant medical conditions as the reason and explicitly stated there are no other circumstances connected with the resignation. The auditor was appointed on 25 September 2025 with a term scheduled to run until 31 March 2030, making this a mid-term exit. The last audit/limited review report was submitted on 7 November 2025. The auditor raised no concerns with management and has no objection to another chartered accountant being appointed in their place.

Likely market impact

Although this is a mid-term auditor resignation, the stated reason is medical and no governance concerns were flagged, which limits red flags. Shareholders should watch for timely appointment of a new statutory auditor to ensure uninterrupted audit coverage and compliance.